Clinical Takeaway
A mobile app called Minder, co-designed with university students, was tested in a randomized controlled trial to address mental health and substance use during the high-risk transition period of university attendance. Digital tools like this are being studied because they can reach large numbers of students in a scalable and acceptable way. Clinicians working with young adult patients should be aware that app-based interventions are an emerging, evidence-informed option worth considering alongside traditional support strategies.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This study addresses a critical clinical gap by evaluating a scalable digital intervention for the high-risk transition period of university attendance, when mental health and substance use disorders commonly emerge. The randomized controlled trial design provides robust evidence on whether mobile app-based interventions can effectively reduce these comorbid conditions in a population that traditionally underutilizes conventional mental health services. Positive findings would support the implementation of accessible, student-centered digital tools that could extend clinical reach and improve early intervention outcomes for this vulnerable population.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 While this randomized controlled trial examining the Minder app for mental health and substance use support in university students addresses an important gap in accessible digital interventions, several factors warrant careful interpretation before widespread clinical recommendation. The study’s focus on a codeveloped app with high user engagement in a motivated student population may not generalize to less engaged or more clinically complex patient populations seen in primary care or addiction medicine settings. Important confounders such as the novelty effect of a newly designed app, selection bias favoring tech-savvy participants, and the potential impact of concurrent mental health treatment or informal support systems remain incompletely characterized from the abstract provided. That said, the randomized design and emphasis on student-centered development suggest this work meaningfully advances our understanding of digital health tools for young adults during a vulnerable life transition. Clinicians working with college-age patients presenting with emerging mood or substance use concerns might reasonably discuss the Minder app as a scalable adjunct to in-person care, while recognizing that app-based interventions